Search

Paul Martens Janeski

Examiner (ID: 4040, Phone: (571)270-1681 , Office: P/3722 )

Most Active Art Unit
3722
Art Unit(s)
3726, 3722
Total Applications
635
Issued Applications
463
Pending Applications
0
Abandoned Applications
175

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18869848 [patent_doc_number] => 11857628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation [patent_app_type] => utility [patent_app_number] => 17/533552 [patent_app_country] => US [patent_app_date] => 2021-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 31 [patent_no_of_words] => 102544 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533552 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/533552
Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation Nov 22, 2021 Issued
Array ( [id] => 17580196 [patent_doc_number] => 20220137051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => IN-VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES [patent_app_type] => utility [patent_app_number] => 17/531314 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531314 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/531314
IN-VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES Nov 18, 2021 Abandoned
Array ( [id] => 17441896 [patent_doc_number] => 20220062401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => VACCINE COMPOSITIONS FOR CLOSTRIDIUM DIFFICILE [patent_app_type] => utility [patent_app_number] => 17/531058 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9055 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531058 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/531058
VACCINE COMPOSITIONS FOR CLOSTRIDIUM DIFFICILE Nov 18, 2021 Pending
Array ( [id] => 17443734 [patent_doc_number] => 20220064239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => Cathelicidin-expressing lactic acid bacteria [patent_app_type] => utility [patent_app_number] => 17/529396 [patent_app_country] => US [patent_app_date] => 2021-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10442 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529396 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/529396
Cathelicidin-expressing lactic acid bacteria Nov 17, 2021 Issued
Array ( [id] => 19035601 [patent_doc_number] => 20240085416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN [patent_app_type] => utility [patent_app_number] => 18/253755 [patent_app_country] => US [patent_app_date] => 2021-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18190 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253755 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/253755
USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN Nov 15, 2021 Pending
Array ( [id] => 17444084 [patent_doc_number] => 20220064589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => NOVEL LACTOBACILLUS PLANTARUM STRAIN ATG-K2, ATG-K6 OR ATG-K8, AND COMPOSITION FOR PREVENTING OR TREATING VAGINITIS COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 17/527002 [patent_app_country] => US [patent_app_date] => 2021-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527002 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/527002
Lactobacillus plantarum strain ATG-K2, ATG-K6 or ATG-K8, and composition for preventing or treating vaginitis comprising same Nov 14, 2021 Issued
Array ( [id] => 18842672 [patent_doc_number] => 20230405076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => COMPOSITION COMPRISING AKKERMANSIA MUCINIPHILA AND GREEN TEA EXTRACT [patent_app_type] => utility [patent_app_number] => 18/035766 [patent_app_country] => US [patent_app_date] => 2021-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5542 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035766 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/035766
COMPOSITION COMPRISING AKKERMANSIA MUCINIPHILA AND GREEN TEA EXTRACT Nov 2, 2021 Pending
Array ( [id] => 18903079 [patent_doc_number] => 20240018564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => IN SITU TWO-PHASE EXTRACTION SYSTEM [patent_app_type] => utility [patent_app_number] => 18/251167 [patent_app_country] => US [patent_app_date] => 2021-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7462 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251167 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251167
IN SITU TWO-PHASE EXTRACTION SYSTEM Oct 31, 2021 Pending
Array ( [id] => 18215265 [patent_doc_number] => 11590178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Application of a bile acid composite bacterial agent in the preparation of feed additives for mutton sheep [patent_app_type] => utility [patent_app_number] => 17/511544 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2117 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511544 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/511544
Application of a bile acid composite bacterial agent in the preparation of feed additives for mutton sheep Oct 25, 2021 Issued
Array ( [id] => 18844840 [patent_doc_number] => 20230407244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => MICROBIAL GROWTH-STIMULATING PROTEIN AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 18/250637 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21137 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250637 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/250637
MICROBIAL GROWTH-STIMULATING PROTEIN AND METHODS OF USING SAME Oct 25, 2021 Abandoned
Array ( [id] => 18896500 [patent_doc_number] => 20240011985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => NEUTRALIZED ANTIBODY AND METHOD OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/032657 [patent_app_country] => US [patent_app_date] => 2021-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13186 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032657 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/032657
NEUTRALIZED ANTIBODY AND METHOD OF USE THEREOF Oct 18, 2021 Pending
Array ( [id] => 18806913 [patent_doc_number] => 20230381246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => GENETICALLY DIVERSE AKKERMANSIA STRAINS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 18/032781 [patent_app_country] => US [patent_app_date] => 2021-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032781 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/032781
GENETICALLY DIVERSE AKKERMANSIA STRAINS AND METHODS OF USING SAME Oct 18, 2021 Pending
Array ( [id] => 18784817 [patent_doc_number] => 20230372464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => CHOLERA VACCINE FORMULATION [patent_app_type] => utility [patent_app_number] => 18/027657 [patent_app_country] => US [patent_app_date] => 2021-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027657 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/027657
CHOLERA VACCINE FORMULATION Oct 5, 2021 Pending
Array ( [id] => 19815076 [patent_doc_number] => 20250073283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-06 [patent_title] => STREPTOCOCCUS FOR USE IN THE TREATMENT OF GLUCOSE INTOLERANCE [patent_app_type] => utility [patent_app_number] => 18/248147 [patent_app_country] => US [patent_app_date] => 2021-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18336 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248147 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/248147
STREPTOCOCCUS FOR USE IN THE TREATMENT OF GLUCOSE INTOLERANCE Oct 5, 2021 Pending
Array ( [id] => 18972205 [patent_doc_number] => 20240052297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => MESOPHILIC, METHYLOTROPHIC BACTERIA FOR THE PH-INDEPENDENT PRODUCTION OF BIOCHEMICALS [patent_app_type] => utility [patent_app_number] => 18/029607 [patent_app_country] => US [patent_app_date] => 2021-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24048 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029607 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/029607
MESOPHILIC, METHYLOTROPHIC BACTERIA FOR THE PH-INDEPENDENT PRODUCTION OF BIOCHEMICALS Sep 29, 2021 Abandoned
Array ( [id] => 19186295 [patent_doc_number] => 20240165208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => Mutant KRAS-Targeting Peptide and Use Thereof [patent_app_type] => utility [patent_app_number] => 18/030222 [patent_app_country] => US [patent_app_date] => 2021-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030222 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/030222
Mutant KRAS-Targeting Peptide and Use Thereof Sep 28, 2021 Pending
Array ( [id] => 17670977 [patent_doc_number] => 20220184144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING SEIZURES [patent_app_type] => utility [patent_app_number] => 17/486299 [patent_app_country] => US [patent_app_date] => 2021-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14239 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17486299 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/486299
Compositions and methods for inhibiting seizures Sep 26, 2021 Issued
Array ( [id] => 18816007 [patent_doc_number] => 20230390346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/028378 [patent_app_country] => US [patent_app_date] => 2021-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028378 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/028378
PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE Sep 23, 2021 Pending
Array ( [id] => 19792195 [patent_doc_number] => 12233118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-25 [patent_title] => Multivalent vaccine compositions and uses thereof [patent_app_type] => utility [patent_app_number] => 17/478584 [patent_app_country] => US [patent_app_date] => 2021-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 53488 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478584 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/478584
Multivalent vaccine compositions and uses thereof Sep 16, 2021 Issued
Array ( [id] => 19896825 [patent_doc_number] => 12274719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-15 [patent_title] => Method for improving walking capacity of elderly subjects [patent_app_type] => utility [patent_app_number] => 17/474885 [patent_app_country] => US [patent_app_date] => 2021-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 0 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474885 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/474885
Method for improving walking capacity of elderly subjects Sep 13, 2021 Issued
Menu